Startseite › Burkitt-Lymphom › Pennsylvania › Philadelphia
Klinische Studien zu Burkitt-Lymphom in Philadelphia, PA
16 Studien zu Burkitt-Lymphom suchen Teilnehmer an Standorten in und um Philadelphia (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Teilnehmer gesuchtPhase 3
- Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Teilnehmer gesuchtPhase 1
- Children's Hospital of Philadelphia, Philadelphia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Teilnehmer gesuchtPhase 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi entfernt
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Teilnehmer gesuchtPhase 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Blinatumomab Consolidation in Real World
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- University of Pennsylvania, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Teilnehmer gesuchtBeobachtungsstudie
- Children's Hospital of Philadelphia, Philadelphia
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Teilnehmer gesuchtPhase 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi entfernt
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Teilnehmer gesuchtPhase 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Teilnehmer gesuchtPhase 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi entfernt
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Teilnehmer gesuchtPhase 3
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi entfernt
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Teilnehmer gesuchtPhase 2
- Children's Hospital of Philadelphia, Philadelphia
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Teilnehmer gesucht
- Children's Hospital of Philadelphia, Philadelphia
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
Teilnehmer gesuchtPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Co-administration of CART22-65s and huCART19 for B-ALL
Teilnehmer gesuchtPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Teilnehmer gesuchtPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Teilnehmer gesuchtPhase 2
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi entfernt
Burkitt-Lymphom-Studien in anderen Städten
- Houston, TX21 Studien
- Milwaukee, WI16 Studien
- Chicago, IL15 Studien
- Cincinnati, OH13 Studien
- New York City, NY13 Studien
- Atlanta, GA12 Studien
- Aurora, CO11 Studien
- Seattle, WA11 Studien
- Durham, NC10 Studien
- Kansas City, MO10 Studien
- Boston, MA10 Studien
- Los Angeles, CA10 Studien
Weitere Studien in Philadelphia
- Krebs (alle Arten)59 Studien
- Brustkrebs56 Studien
- Nichtkleinzelliges Lungenkarzinom51 Studien
- Metastasierender Krebs46 Studien
- Prostatakrebs44 Studien
- Kolorektales Karzinom44 Studien
- Eierstockkrebs44 Studien
- Lungenkrebs36 Studien
- Akute myeloische Leukämie34 Studien
- Herzinsuffizienz31 Studien
- Endometriumkarzinom28 Studien
- Depression26 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.